Global Blood Therapeutics Inc. News
Stock Market Today – 8/8: Stocks End Mixed as Investors Look to July Inflation Numbers
Stocks finish mixed as investors assess the Senate's sweeping bill on clean energy, health care and taxes, and await key inflation numbers for July.
Microsoft, Qorvo, EA: Analysts' Upgrades and Downgrades
TheStreet's weekly guide to upgrades and price target changes includes Microsoft, Electronic Arts and Qorvo.
Global Blood Therapeutics Off on Results Miss, Analyst Rating Cut
Global Blood Therapeutics shares are lower after the company missed analysts' revenue and earnings expectations.
Rate Cut's No Cure: Cramer's 'Mad Money' Recap (Tuesday 3/3/20)
Jim Cramer didn’t want this rate cut. He says it spooked the most important market there is, the bond market. Buy some gold.
Holiday Gift List: Cramer's 'Mad Money' Recap (Friday 12/20/19)
Jim Cramer has a list of 12 presents he'd love to see investors get this holiday season, from a prosperous stock market to a true resolution of the trade wars in the coming year.
The Fed and Trump Are Both Wrong: Cramer's 'Mad Money' Recap
Markets looking for reassurance aren't getting any from the White House or the Federal Reserve, Jim Cramer says.
Biotech Movers: Global Blood Shares Rise on PRIME Designation
Global Blood Therapeutics, Kite Pharma and Bellicum Pharmaceuticals were among the biotech movers in premarket trading on June 28.
Sticker Shock: Ford Lifts Price Tag on 2023 F-150 Lightning Pro, Again
Those waiting to get their hands on Ford's all-electric F-150 Lightning aren’t just going to have to wait longer. They’re going to have to pay more.
More Details Emerge About Universal Studios' Disney World Killer
Universal Studios has begun construction on Epic Universe, its third theme park planned for Florida.